BIO-key International (NASDAQ: BKYI) makes the Nasdaq top gainer list, up 37.14%, after a Middle East government institution ...

The Silver Engineer on September's silver buying: mint sales and Indian fund inflows, India's easier import rules, China's ...

Anna Radomska on the dollar's new bearish gap near 101.51-101.60 and gold's test of the 4098-4135 weekly bullish gap, with ...

Aamir Iqbal's Daily Gold Trading Report for October 22: spot gold slides near $4,111 after $4,141 rejected three probes, with ...

Vere Group CEO Nigel Green on AI-found PHP flaws forcing governments offline and why a prepaid card can limit exposure to ...

Paul Rejczak on why the S&P 500 is likely to give back yesterday's gains, with key resistance and support levels for the ...

SpaceX (Nasdaq: SPCX) trends and gains after third quarter results: revenue of $14.6 billion, up 161%, net income of $4.4 ...

Vere CEO Nigel Green warns UK inflation at 3.5% points to Bank of England rate hikes in November and December, squeezing ...

Aamir Iqbal's Daily Gold Trading Report for October 21: spot gold holds near $4,119 after a failed $4,155 spike, with $4,132 ...

Anna Radomska on the dollar sliding through key support while gold struggles near its weekly bullish gap, with the key ...

Myriad Genetics (NASDAQ: MYGN) soars 36.94% on news it will sell its Prenatal Health testing business to Labcorp for $210 ...

Arcus Biosciences (NYSE:RCUS) makes the NYSE top gainer list, up 9.53% on new ARC-20 data for casdatifan in clear cell renal cell carcinoma.